dapsone has been researched along with Disease Models, Animal in 56 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluate the effect of dapsone on tactile allodynia and mechanical hyperalgesia and to determine its anti-oxidant effect in a spinal cord injury (SC) model in rats." | 8.02 | Dapsone Prevents Allodynia and Hyperalgesia and Decreased Oxidative Stress After Spinal Cord Injury in Rats. ( Burelo, M; Calderón-Estrella, F; Camilo, R; Diaz-Ruiz, A; García-Martínez, BA; Jardon-Guadarrama, G; Mata-Bermudez, A; Pérez-González, C; Rangel-Hernández, A, 2021) |
| "In this study, colitis was induced by instillation of 2,4,6-trinitrobenzenesulfonic acid (TNBS) 100 mg/kg." | 8.02 | Dapsone Ameliorates Colitis through TLR4/NF-kB Pathway in TNBS Induced Colitis Model in Rat. ( Ala, M; Dehpour, AR; Hashemian, SM; Mohammad Jafari, R; Rashidian, A; Shayesteh, S; Sorouri, M; Yousefi-Manesh, H, 2021) |
| "Dapsone is a sulfone chemical with reported anti-inflammatory and antibacterial properties." | 5.72 | The anti-inflammatory effect of dapsone on ovalbumin-induced allergic rhinitis in balb/c mice. ( Alaeddini, M; Dabiri, S; Dehpour, AR; Etemad-Moghadam, S; Fatehi-Zardalou, M; Hemmati, S; Madanipour, MR; Rahimi, N; Shayan, M, 2022) |
| "To investigate this, we created a hemorrhagic shock model rat, followed by resuscitation with RBC and CO-RBC." | 5.40 | Carbon monoxide-bound red blood cell resuscitation ameliorates hepatic injury induced by massive hemorrhage and red blood cell resuscitation via hepatic cytochrome P450 protection in hemorrhagic shock rats. ( Ishima, Y; Maruyama, T; Ogaki, S; Otagiri, M; Taguchi, K; Watanabe, H, 2014) |
| "Dapsone has been shown to possess anti-inflammatory activity in a variety of animal models." | 5.26 | The anti-inflammatory profile of dapsone in animal models of inflammation. ( Gemmell, DK; Lewis, AJ; Stimson, WH, 1978) |
| "We evaluate the effect of dapsone on tactile allodynia and mechanical hyperalgesia and to determine its anti-oxidant effect in a spinal cord injury (SC) model in rats." | 4.02 | Dapsone Prevents Allodynia and Hyperalgesia and Decreased Oxidative Stress After Spinal Cord Injury in Rats. ( Burelo, M; Calderón-Estrella, F; Camilo, R; Diaz-Ruiz, A; García-Martínez, BA; Jardon-Guadarrama, G; Mata-Bermudez, A; Pérez-González, C; Rangel-Hernández, A, 2021) |
| "In this study, colitis was induced by instillation of 2,4,6-trinitrobenzenesulfonic acid (TNBS) 100 mg/kg." | 4.02 | Dapsone Ameliorates Colitis through TLR4/NF-kB Pathway in TNBS Induced Colitis Model in Rat. ( Ala, M; Dehpour, AR; Hashemian, SM; Mohammad Jafari, R; Rashidian, A; Shayesteh, S; Sorouri, M; Yousefi-Manesh, H, 2021) |
| "5-(2-Pyridylsulfonyl)-2-thiazolamine (2) was effective both in mitomycin C (MMC)-induced thrombocytopenia and in an animal model of idiopathic thrombocytopenic purpura (ITP)." | 3.70 | Synthesis and effects of novel thiazole derivatives against thrombocytopenia. ( Manda, T; Matsuo, M; Nishigaki, F; Ogino, T; Sawada, M; Seki, N; Sudo, Y; Tsuji, K, 1998) |
| "Dapsone (DAP) is a long-established molecule that remains a promising therapeutic agent for various diseases mainly because it combines antimicrobial and anti-inflammatory activities." | 2.66 | Emerging Technologies to Target Drug Delivery to the Skin - the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone. ( Argenta, DF; Caon, T; Schneider-Rauber, G, 2020) |
| "Dapsone has been investigated predominantly by in vitro methods aiming to get more insights into the effect of dapsone to inflammatory effector cells, cytokines, and/or mediators, such as cellular toxic oxygen metabolism, myoloperoxidase-/halogenid system, adhesion molecules, chemotaxis, membrane-associated phospholipids, prostaglandins, leukotrienes, interleukin-8, tumor necrosis factor α, lymphocyte functions, and tumor growth." | 2.50 | Dapsone in dermatology and beyond. ( Blasum, C; Wozel, G, 2014) |
| "Colchicine and dapsone have been reported to be good treatment modalities when combined with corticosteroids." | 2.49 | Epidermolysis bullosa acquisita. ( Kim, JH; Kim, SC, 2013) |
| "DH is associated to a gluten enteropathy and its physiopathology is better known." | 2.47 | [Dermatitis herpetiformis: a review]. ( Ingen-Housz-Oro, S, 2011) |
| "Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial disease of the lung tissue that causes symptoms such as coughing and asthma." | 1.72 | Protective effect of dapsone against bleomycin-induced lung fibrosis in rat. ( Asgardoon, MH; Dehpour, AR; Derakhshan, MH; Noori, T; Sheibani, M; Shirooie, S; Tavangar, SM; Yousefi-Manesh, H, 2022) |
| "Dapsone is a sulfone chemical with reported anti-inflammatory and antibacterial properties." | 1.72 | The anti-inflammatory effect of dapsone on ovalbumin-induced allergic rhinitis in balb/c mice. ( Alaeddini, M; Dabiri, S; Dehpour, AR; Etemad-Moghadam, S; Fatehi-Zardalou, M; Hemmati, S; Madanipour, MR; Rahimi, N; Shayan, M, 2022) |
| "Male adult Wistar rats were subjected to middle cerebral artery occlusion (MCAO) for 90 min followed by 24 h of ischemic reperfusion (I/R)." | 1.56 | Dapsone prolong delayed excitotoxic neuronal cell death by interacting with proapoptotic/survival signaling proteins. ( Gakare, S; Kumar, R; Mahale, A; Prakash, A; Sarode, LP; Ugale, RR, 2020) |
| "To investigate this, we created a hemorrhagic shock model rat, followed by resuscitation with RBC and CO-RBC." | 1.40 | Carbon monoxide-bound red blood cell resuscitation ameliorates hepatic injury induced by massive hemorrhage and red blood cell resuscitation via hepatic cytochrome P450 protection in hemorrhagic shock rats. ( Ishima, Y; Maruyama, T; Ogaki, S; Otagiri, M; Taguchi, K; Watanabe, H, 2014) |
| "Dapsone-treated animals showed a reduction of 93% (9." | 1.32 | Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats. ( Nader-Kawachi, J; Nava-Ruiz, C; Ríos, C; Rodriguez-Payán, AJ, 2004) |
| "The ME7 scrapie-infected mice thus showed a characteristic complex of neurological and behavioural changes during the course of the disease that were not ameliorated by dapsone." | 1.31 | Early behavioural changes in scrapie-affected mice and the influence of dapsone. ( Deacon, RM; Guenther, K; Perry, VH; Rawlins, JN, 2001) |
| " Extending these experiments, we have now shown that roxithromycin at doses of 400 or 200 mg/kg/day combined with dapsone at doses of 5, 25 or 50 mg/kg/day completely prevented the development of T." | 1.30 | Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model. ( Brun-Pascaud, M; Chau, F; Derouin, F; Girard, PM, 1998) |
| " Ro 11-8958, TMP, and diaveridine used at a dosage of 20 mg/kg/day with SMX were only slightly more effective than SMX used alone." | 1.29 | Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis. ( Foy, J; Steele, P; Walzer, PD; White, M, 1993) |
| " carinii in vitro, a clinical trial of reduced dosage of dapsone given prophylactically to human beings is suggested." | 1.28 | Dapsone in low doses prevents Pneumocystis carinii pneumonia in the rat model. ( González-Ruiz, A; Haworth, SJ; O'Neil, AB; Warhurst, DC, 1991) |
| "The purpose of this study was to identify new drugs for the prevention and treatment of Pneumocystis carinii pneumonitis (PCP) induced in rats by continuous daily dosage with dexamethasone." | 1.27 | Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis. ( Hughes, WT; Smith, BL, 1984) |
| "Suramin and dapsone were weakly active." | 1.27 | Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia. ( Clarkson, AB; Rosenberg, C; Williams, DE, 1988) |
| "Dapsone has been shown to possess anti-inflammatory activity in a variety of animal models." | 1.26 | The anti-inflammatory profile of dapsone in animal models of inflammation. ( Gemmell, DK; Lewis, AJ; Stimson, WH, 1978) |
| " Treatment with the smaller dosage of dapsone neither killed M." | 1.26 | Dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat. ( Fieldsteel, AH; Levy, L, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (42.86) | 18.7374 |
| 1990's | 11 (19.64) | 18.2507 |
| 2000's | 5 (8.93) | 29.6817 |
| 2010's | 7 (12.50) | 24.3611 |
| 2020's | 9 (16.07) | 2.80 |
| Authors | Studies |
|---|---|
| Ogino, T | 2 |
| Tsuji, K | 2 |
| Tojo, T | 1 |
| Igari, N | 1 |
| Seki, N | 2 |
| Sudo, Y | 2 |
| Manda, T | 2 |
| Nishigaki, F | 2 |
| Matsuo, M | 2 |
| Sawada, M | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Mata-Bermudez, A | 1 |
| Diaz-Ruiz, A | 2 |
| Burelo, M | 1 |
| García-Martínez, BA | 1 |
| Jardon-Guadarrama, G | 1 |
| Calderón-Estrella, F | 1 |
| Rangel-Hernández, A | 1 |
| Pérez-González, C | 1 |
| Camilo, R | 1 |
| Yousefi-Manesh, H | 2 |
| Noori, T | 1 |
| Asgardoon, MH | 1 |
| Derakhshan, MH | 1 |
| Tavangar, SM | 1 |
| Sheibani, M | 1 |
| Shirooie, S | 1 |
| Dehpour, AR | 3 |
| Madanipour, MR | 1 |
| Fatehi-Zardalou, M | 1 |
| Rahimi, N | 1 |
| Hemmati, S | 1 |
| Alaeddini, M | 1 |
| Etemad-Moghadam, S | 1 |
| Shayan, M | 1 |
| Dabiri, S | 1 |
| Mahale, A | 1 |
| Kumar, R | 1 |
| Sarode, LP | 1 |
| Gakare, S | 1 |
| Prakash, A | 1 |
| Ugale, RR | 1 |
| Schneider-Rauber, G | 1 |
| Argenta, DF | 1 |
| Caon, T | 1 |
| Moksha, L | 1 |
| Halder, N | 1 |
| Singh, SB | 1 |
| Chawla, R | 1 |
| Kumar, A | 1 |
| Velpandian, T | 1 |
| Mohammad Jafari, R | 1 |
| Shayesteh, S | 1 |
| Ala, M | 1 |
| Rashidian, A | 1 |
| Hashemian, SM | 1 |
| Sorouri, M | 1 |
| Murthy, S | 1 |
| Schilf, P | 1 |
| Patzelt, S | 1 |
| Thieme, M | 1 |
| Becker, M | 1 |
| Kröger, L | 1 |
| Bremer, T | 1 |
| Derenda-Hell, A | 1 |
| Knebel, L | 1 |
| Fagiani, F | 1 |
| Ibrahim, SM | 1 |
| Schmidt, E | 1 |
| Zillikens, D | 1 |
| Sadik, CD | 1 |
| Wozel, G | 1 |
| Blasum, C | 1 |
| Ogaki, S | 1 |
| Taguchi, K | 1 |
| Watanabe, H | 1 |
| Ishima, Y | 1 |
| Otagiri, M | 1 |
| Maruyama, T | 1 |
| Lee, YI | 1 |
| Kang, H | 1 |
| Ha, YW | 1 |
| Chang, KY | 1 |
| Cho, SC | 1 |
| Song, SO | 1 |
| Kim, H | 1 |
| Jo, A | 1 |
| Khang, R | 1 |
| Choi, JY | 1 |
| Lee, Y | 1 |
| Park, SC | 1 |
| Shin, JH | 1 |
| Salgado-Ceballos, H | 1 |
| Montes, S | 1 |
| Guizar-Sahagún, G | 1 |
| Gelista-Herrera, N | 1 |
| Mendez-Armenta, M | 1 |
| Diaz-Cintra, S | 1 |
| Ríos, C | 2 |
| Ingen-Housz-Oro, S | 1 |
| Kanoh, S | 1 |
| Tanabe, T | 1 |
| Rubin, BK | 1 |
| Kim, JH | 1 |
| Kim, SC | 1 |
| Nader-Kawachi, J | 1 |
| Rodriguez-Payán, AJ | 1 |
| Nava-Ruiz, C | 1 |
| Marietta, E | 1 |
| Black, K | 1 |
| Camilleri, M | 1 |
| Krause, P | 1 |
| Rogers, RS | 1 |
| David, C | 1 |
| Pittelkow, MR | 1 |
| Murray, JA | 1 |
| Makarov, V | 1 |
| Riabova, OB | 1 |
| Yuschenko, A | 1 |
| Urlyapova, N | 1 |
| Daudova, A | 1 |
| Zipfel, PF | 1 |
| Möllmann, U | 1 |
| Hughes, WT | 3 |
| Smith, BL | 1 |
| Moschella, SL | 1 |
| Shetty, VP | 1 |
| Antia, NH | 1 |
| Killmar, JT | 1 |
| Oz, HS | 1 |
| Walzer, PD | 1 |
| Foy, J | 1 |
| Steele, P | 1 |
| White, M | 1 |
| Cole, HP | 1 |
| Wesley, RE | 1 |
| King, LE | 1 |
| Yeo, AE | 1 |
| Brun-Pascaud, M | 1 |
| Chau, F | 1 |
| Derouin, F | 1 |
| Girard, PM | 1 |
| Guenther, K | 1 |
| Deacon, RM | 1 |
| Perry, VH | 1 |
| Rawlins, JN | 1 |
| Veggi, LM | 1 |
| Crocenzi, FA | 1 |
| Roma, MG | 1 |
| Dawson, PA | 1 |
| Pellegrino, JM | 1 |
| Sánchez Pozzi, EJ | 1 |
| Mottino, AD | 1 |
| Lewis, AJ | 1 |
| Gemmell, DK | 1 |
| Stimson, WH | 1 |
| Loginov, VK | 1 |
| Pogorelov, VN | 1 |
| Fieldsteel, AH | 1 |
| Levy, L | 1 |
| Davidson, DE | 1 |
| Johnsen, DO | 1 |
| Tanticharoenyos, P | 1 |
| Hickman, RL | 1 |
| Kinnamon, KE | 1 |
| Leiker, DL | 1 |
| Banerjee, DK | 1 |
| McDermott-Lancaster, RD | 1 |
| Cook, RM | 1 |
| González-Ruiz, A | 1 |
| Haworth, SJ | 1 |
| O'Neil, AB | 1 |
| Warhurst, DC | 1 |
| Clarkson, AB | 1 |
| Williams, DE | 1 |
| Rosenberg, C | 1 |
| Gelber, RH | 1 |
| Vischer, WA | 1 |
| Browne, SG | 4 |
| Rosenfeld, M | 2 |
| Rees, RJ | 2 |
| Freerksen, E | 1 |
| Weddell, AG | 1 |
| Ozawa, T | 1 |
| Shepard, CC | 2 |
| Karat, AB | 1 |
| Yeary, RA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neuroprotective Effect of Dapsone in Patients With Aneurysmal Subarachnoid Hemorrhage: Prospective, Randomized, Double-Blinded, Placebo-Controlled, Clinical Trial[NCT05131295] | Phase 3 | 49 participants (Actual) | Interventional | 2007-09-05 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for dapsone and Disease Models, Animal
| Article | Year |
|---|---|
Emerging Technologies to Target Drug Delivery to the Skin - the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone.
Topics: Administration, Cutaneous; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemistry, Phar | 2020 |
Dapsone in dermatology and beyond.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatology; Disea | 2014 |
[Dermatitis herpetiformis: a review].
Topics: Adult; Animals; Autoantibodies; Celiac Disease; Child; Combined Modality Therapy; Complement C3; Dap | 2011 |
Epidermolysis bullosa acquisita.
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Autoimmune | 2013 |
Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Clinical Trials as To | 1998 |
[Progress in leprology in recent years].
Topics: Animals; Dapsone; Dihydroxyphenylalanine; Disease Models, Animal; Humans; L-Lactate Dehydrogenase; L | 1975 |
Chemotherapy in Leprosy.
Topics: Acetamides; Anemia, Hemolytic; Aniline Compounds; Animals; Clofazimine; Dapsone; Disease Models, Ani | 1975 |
The evaluation of present antileprosy compounds.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Resi | 1969 |
Recent advances in experimental leprosy.
Topics: Africa; Animals; BCG Vaccine; Dapsone; Disease Models, Animal; Humans; Independent State of Samoa; I | 1970 |
Summary of recent abstracts. 8. Leprosy.
Topics: Animals; Antibody Formation; BCG Vaccine; Dapsone; Disease Models, Animal; Guinea Pigs; Humans; Lepr | 1970 |
The evaluation of present antileprosy compounds.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; BCG Vaccine; Clinical Trials as Topic; Dapson | 1969 |
Summary of recent abstracts. 8. Leprosy.
Topics: Animals; Dapsone; Disease Models, Animal; Humans; Leprosy; Mice; Phenazines; Thalidomide | 1971 |
The first decade in experimental leprosy.
Topics: Animals; BCG Vaccine; Clofazimine; Dapsone; Disease Models, Animal; Drug Evaluation; Drug Evaluation | 1971 |
2 trials available for dapsone and Disease Models, Animal
| Article | Year |
|---|---|
The evaluation of present antileprosy compounds.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Resi | 1969 |
The evaluation of present antileprosy compounds.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; BCG Vaccine; Clinical Trials as Topic; Dapson | 1969 |
43 other studies available for dapsone and Disease Models, Animal
| Article | Year |
|---|---|
Discovery of FR115092: a novel antinephritic agent.
Topics: Anemia; Animals; Disease Models, Animal; Male; Mice; Nephritis; Pyridines; Thiazoles | 1998 |
Synthesis and effects of novel thiazole derivatives against thrombocytopenia.
Topics: Animals; Autoantibodies; Blood Platelets; Dapsone; Disease Models, Animal; Dose-Response Relationshi | 1998 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Dapsone Prevents Allodynia and Hyperalgesia and Decreased Oxidative Stress After Spinal Cord Injury in Rats.
Topics: Animals; Dapsone; Disease Models, Animal; Hyperalgesia; Neuralgia; Oxidative Stress; Prospective Stu | 2021 |
Protective effect of dapsone against bleomycin-induced lung fibrosis in rat.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bleomycin; Catalase; Dapsone; Disease Models, Anima | 2022 |
The anti-inflammatory effect of dapsone on ovalbumin-induced allergic rhinitis in balb/c mice.
Topics: Animals; Cytokines; Dapsone; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Nasal Mucosa | 2022 |
Dapsone prolong delayed excitotoxic neuronal cell death by interacting with proapoptotic/survival signaling proteins.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain; Cells, Cultured; Dapsone; Disease Models, | 2020 |
Pharmacoproteomic analysis of topical dapsone and prednisolone interventions in the aqueous humor of anterior uveitis.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Aqueous Humor; Dapsone; Disease Models, Ani | 2021 |
Dapsone Ameliorates Colitis through TLR4/NF-kB Pathway in TNBS Induced Colitis Model in Rat.
Topics: Animals; Colitis; Colon; Dapsone; Disease Models, Animal; Humans; NF-kappa B; Rats; Signal Transduct | 2021 |
Dapsone Suppresses Disease in Preclinical Murine Models of Pemphigoid Diseases.
Topics: Animals; Cell Adhesion Molecules; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; | 2021 |
Carbon monoxide-bound red blood cell resuscitation ameliorates hepatic injury induced by massive hemorrhage and red blood cell resuscitation via hepatic cytochrome P450 protection in hemorrhagic shock rats.
Topics: Animals; Carbon Monoxide; Cytochrome P-450 Enzyme System; Dapsone; Disease Models, Animal; Erythrocy | 2014 |
Diaminodiphenyl sulfone-induced parkin ameliorates age-dependent dopaminergic neuronal loss.
Topics: Activating Transcription Factor 4; Aging; Animals; Anti-Inflammatory Agents; Brain; Cells, Cultured; | 2016 |
Delayed administration of dapsone protects from tissue damage and improves recovery after spinal cord injury.
Topics: Animals; Dapsone; Disease Models, Animal; Female; Folic Acid Antagonists; Lipid Peroxidation; Motor | 2011 |
Dapsone inhibits IL-8 secretion from human bronchial epithelial cells stimulated with lipopolysaccharide and resolves airway inflammation in the ferret.
Topics: Administration, Oral; Aerosols; Animals; Anti-Inflammatory Agents; Bronchi; Bronchitis; Cell Surviva | 2011 |
Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats.
Topics: Animals; Brain Infarction; Brain Ischemia; Dapsone; Disease Models, Animal; Dose-Response Relationsh | 2004 |
A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatitis Herpetiformis; Diet; Disease M | 2004 |
Synthesis and antileprosy activity of some dialkyldithiocarbamates.
Topics: Animals; Colony Count, Microbial; Dapsone; Disease Models, Animal; Drug Therapy, Combination; Humans | 2006 |
Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis.
Topics: Animals; Dapsone; Disease Models, Animal; Drug Combinations; Male; Pneumonia, Pneumocystis; Rats; Ra | 1984 |
Leprosy today.
Topics: Clofazimine; Dapsone; Disease Models, Animal; Drug Resistance, Microbial; Humans; Leprosy; Mycobacte | 1983 |
Multiple axonal myelination in the experimental mouse leprosy model.
Topics: Animals; Axons; Dapsone; Disease Models, Animal; Female; Leprosy; Mice; Mycobacterium leprae; Nerve | 1984 |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Tria | 1994 |
Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
Topics: AIDS-Related Opportunistic Infections; Animals; Dapsone; Disease Models, Animal; Dose-Response Relat | 1993 |
Brown recluse spider envenomation of the eyelid: an animal model.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antivenins; Combined Modality Therapy; Dap | 1995 |
Direct comparison of antimalarial activity among PS-15 combination therapies by bioassay of serum samples from treated Saimiri sciureus.
Topics: Animals; Antimalarials; Atovaquone; Biological Assay; Dapsone; Disease Models, Animal; Drug Synergis | 1997 |
Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Disease Models, Animal; Dose-Respons | 1998 |
Early behavioural changes in scrapie-affected mice and the influence of dapsone.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Avoidance Learning; Behavior, Animal; Body Weight; | 2001 |
Dapsone-induced cholestasis and impairment of bile salt output in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bile Acids and Salts; Biomarkers; Body Weight; Car | 2002 |
The anti-inflammatory profile of dapsone in animal models of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; | 1978 |
Dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
Topics: Animals; Animals, Newborn; Dapsone; Disease Models, Animal; Female; Leprosy; Male; Mice; Mice, Inbre | 1976 |
Evaluating new antimalarial drugs against trophozoite induced Plasmodium cynomolgi malaria in rhesus monkeys.
Topics: Amodiaquine; Animals; Antimalarials; Dapsone; Disease Models, Animal; Dose-Response Relationship, Dr | 1976 |
An experimental study to evaluate the bactericidal activity of ofloxacin against an established Mycobacterium leprae infection.
Topics: Animals; Dapsone; Disease Models, Animal; Drug Therapy, Combination; Leprosy; Mice; Mice, Nude; Myco | 1992 |
Eosinophil accumulation in rats injected with Sephadex particles.
Topics: Animals; Dapsone; Dexamethasone; Dextrans; Disease Models, Animal; Eosinophilia; Eosinophils; Inject | 1990 |
Dapsone in low doses prevents Pneumocystis carinii pneumonia in the rat model.
Topics: Administration, Oral; Animals; Dapsone; Diet; Disease Models, Animal; Immune Tolerance; Male; Pneumo | 1991 |
Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Dapsone; Diminazene; Disease Models, Animal; Drug Com | 1988 |
The neonatally thymectomized rat as a model of the lepromatous patient.
Topics: Animals; Animals, Newborn; Dapsone; Disease Models, Animal; Humans; Immunotherapy; Leprosy; Mice; My | 1987 |
[Comparative study on the effect of some clinically used sulfanilamide derivatives against toxoplasmosis in the mouse].
Topics: Aminobenzoates; Animals; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Syn | 1973 |
[Chemotherapy of so-called atypical mycobacterioses].
Topics: Animals; Antitubercular Agents; Cycloserine; Dapsone; Disease Models, Animal; Drug Synergism; Ethamb | 1968 |
Editorial: Prevention of leprosy.
Topics: Animals; Bacteriological Techniques; Body Temperature; Child; Dapsone; Disease Models, Animal; Human | 1974 |
A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
Topics: Aniline Compounds; Animals; Dapsone; Disease Models, Animal; Drug Combinations; Ethionamide; Humans; | 1972 |
Transmission of human leprosy to the mouse and its clinical implications.
Topics: Animals; Communicable Diseases; Dapsone; Disease Models, Animal; Drug Resistance, Microbial; Hindlim | 1970 |
Application of spectrophotofluorometric procedures to some problems in Mycobacterium leprae infections in mice and man treated with dapsone (DDS), diacetyl-DDS (DADDS), and di-formyl-DDS (DFD).
Topics: Acetates; Animals; Colorimetry; Dapsone; Disease Models, Animal; Fluorometry; Formates; Half-Life; H | 1971 |
WHO expert committee on leprosy.
Topics: Attitude to Health; BCG Vaccine; Dapsone; Disability Evaluation; Disease Models, Animal; Health Educ | 1970 |
Comparative toxicity studies on glucuronide-forming compounds in icteric and nonicteric newborn Gunn rats.
Topics: Aminobenzoates; Analgesics; Aniline Compounds; Animals; Animals, Newborn; Chloramphenicol; Dapsone; | 1970 |